Arbutus sues Pfizer and BioNTech over LNP patents in 3 countries

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. NDAQ

Go back to Arbutus sues Pfizer and BioNTech over LNP patents in 3 countries

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to

July 16, 2026 7:30 AM EDT

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (LNP) technology against Pfizer and BioNTech 

Received approximately $178M from Moderna as Arbutus share of the noncontingent payment under the March 2026 Settlement Agreement resolving litigation over Modernas infringement of Arbutus LNP patents

Anticipates receipt of a dividend from Genevant in Q3 2026

Expects to return up to approximately $230M in capital to Arbutus shareholders

WARMINSTER, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma... More